Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × kalinox × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 1

Interventions

Cytarabine 22 Cyclophosphamide 20 Daunorubicin 13 venetoclax 12 Methotrexate 12 Etoposide 10 Dexamethasone 10 Vincristine 9 Idarubicin 9 Decitabine 8 Busulfan 8 Stem Cell Transplantation 7 Radiotherapy 7 Prednisone 7 Azacitidine 7 fludarabine phosphate 6 fludarabine 6 Mercaptopurine 6 Gemtuzumab 6 Doxorubicin 6 Asparaginase 6 pegaspargase 5 Thiotepa 5 Filgrastim 5 Dasatinib 5 blinatumomab 4 Methylprednisolone 4 Melphalan 4 Cyclosporine 4 thymoglobulin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03483194 2020-06-23

REVEH

Weprom

Phase 2/3 Completed

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡